ArticleJournal of neuroinflammation2026
Impaired removal of dying brain cells by microglia in Gpr34 deficient mice.
Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
GPR34, a G protein-coupled receptor present selectively in microglia and other myeloid cells, is highly expressed in homeostatic microglia but is downregulated in disease associated microglia (DAM) such as those found in Alzheimer’s disease brain. However, little is known about GPR34’s role in microglia function or brain development. Here, we studied Gpr34 knockout (KO) mice at postnatal 18-day (P18) and 3 months (3 mo) age. In the brains of P18 Gpr34 KO mice, there were elevated numbers of neurons, oligodendrocytes and microglia, many of which were IHC-positive for the cell death markers cleaved-caspase 3, phospho-RIP3, or annexin V. P18 KO animals showed a reduced localization of microglia in areas of high cell death, while the increased evidence of cell death way largely resolved in 3 mo animals. While the uptake of bacterial particles was not impacted ex-vivo, KO microglia showed increased intracellular accumulation of endogenous cargo, myelin basic protein (MBP) and synaptosomal-associated protein 25 (SNAP25), suggesting altered handling of apoptotic debris without a global phagocytic defect. Notably, transcriptomic analysis revealed persistent impact of immune pathways even at 3 months, at the stage where KO mice also displayed sustained hypolocomotion. Collectively, these results indicate that murine Gpr34 contributes to early clearance of dying cells and may influence a long-lasting impact on microglia state and behavior.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.